Pilot study comparing technologies to test for substandard drugs in field settings

Roger Bate^{1, 2}*, Richard Tren^2,3, Kimberly Hess², Lorraine Mooney⁴ and Karen Porter¹

¹American Enterprise Institute, 1150 Seventeenth Street, NW, Washington, DC 20036, USA.

²Africa Fighting Malaria, 1050 Seventeenth Street, NW, Suite 590, Washington, DC 20036, USA.

³Africa Fighting Malaria, P. O. Box 17156 Congella, 4013, South Africa.

⁴Africa Fighting Malaria, 4 Church Lane, Barton, Cambridge, CB3 7BE, UK.

Received: 2011-02-17Accepted: 2025-03-13Published: 2011-02-17

Int. J. Pharm. & Pharmacol. 2011, 2(1), 1-6

Disclaimer: The statements, opinions and data contained in this journal are solely those of the individual authors and contributors and not of Macao Scientific Publishers and/or the editors. Macao Scientific Publishers and/or the editors disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content.